Kelly McCabe Gillen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kelly McCabe Gillen has a total of 183 co-authors. Here are the top co-authors by number of shared publications:
- Yi Wang
Department of Radiology Weill Cornell Medicine New York New York USA
15 shared publications Ajay Gupta
Columbia University
7 shared publicationsPascal Spincemaille
Department of Radiology, Weill Cornell Medicine, New York, NY, 10065, USA
6 shared publicationsThanh D. Nguyen
Department of Radiology Weill Cornell Medicine New York New York USA
5 shared publicationsDavid Pitt
Department of Neurology, Yale School of Medicine , New Haven, CT 06511
4 shared publications- David Pitt
Yale School of Medicine
4 shared publications
Latest Publications
- Open Access
- 20 April 2026
- Published by SAGE Publications in Journal of Medical Education and Curricular Development
- Vol. 13
Transitioning from National Institutes of Health Career Development Awards to R01-Equivalent Awards in Clinical Departments
There are 15 research career development awards from the NIH, but 70% of funding is allocated to just four awards: K01, K08, K23, and K99. We analyzed K01, K08, K23, and K25 mentored career development awardees and quantified if they received subsequent independent research project grants such as an R01 or an R01-equivalent award (R01 + ) within 5 years of the K award end date. All data were from NIH RePORTER and limited to clinical departments. All K01, K08, K23, and K25 researchers (n = 7711) were identified through a search from NIH Fiscal Year (FY) 2007 to FY 2021. NIH datafiles for FY 2007 to FY 2021 were aggregated to generate a master datafile of all R01 + awards (n= 552,396). Each R01 + award was then linked to the corresponding K awardee previously identified through the K awards search. There was a gradual increase in R01 + success rates as time from the end of the K award increased; however, 5 years after the K award end date, less than half of the awardees had an R01 + as contact PI. Therefore, should a K awardee remain in academia, a substantial percentage may require institutional support and/or pursue funding in roles other than contact PI on an NIH grant in order to support their research programs. These findings may be useful to junior investigators as they plan their K grant applications and to clinical departments as they evaluate K awardees for independent research positions.
- 20 April 2026
- Published by SAGE Publications in Journal of Medical Education and Curricular Development
- Vol. 13
Open AccessTransitioning from National Institutes of Health Career Development Awards to R01-Equivalent Awards in Clinical Departments
There are 15 research career development awards from the NIH, but 70% of funding is allocated to just four awards: K01, K08, K23, and K99. We analyzed K01, K08, K23, and K25 mentored career development awardees and quantified if they received subsequent independent research project grants such as an R01 or an R01-equivalent award (R01 + ) within 5 years of the K award end date. All data were from NIH RePORTER and limited to clinical departments. All K01, K08, K23, and K25 researchers (n = 7711) were identified through a search from NIH Fiscal Year (FY) 2007 to FY 2021. NIH datafiles for FY 2007 to FY 2021 were aggregated to generate a master datafile of all R01 + awards (n= 552,396). Each R01 + award was then linked to the corresponding K awardee previously identified through the K awards search. There was a gradual increase in R01 + success rates as time from the end of the K award increased; however, 5 years after the K award end date, less than half of the awardees had an R01 + as contact PI. Therefore, should a K awardee remain in academia, a substantial percentage may require institutional support and/or pursue funding in roles other than contact PI on an NIH grant in order to support their research programs. These findings may be useful to junior investigators as they plan their K grant applications and to clinical departments as they evaluate K awardees for independent research positions.
- 15 October 2025
- Published by Elsevier in Academic Radiology
- Vol. 33 (1) , 15-19
Trends in R01 and R01 Equivalent Funding to Radiology
- 15 October 2025
- Published by Elsevier in Academic Radiology
- Vol. 33 (1) , 15-19
Trends in R01 and R01 Equivalent Funding to Radiology
- Open Access
- 25 March 2025
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 31 (3) , e70355
Association of Increased Brain Iron Levels With Anxiety and Motor Dysfunction in Cerebral Small Vessel Disease
Aims: This study explored the relationships between brain iron levels, emotion, and cognitive and motor function in cerebral small vessel disease (CSVD) patients using quantitative susceptibility mapping (QSM).Methods: A total of 208 subjects were enrolled in this study. A brain QSM map was calculated from multiecho GRE data via morphology‐enabled dipole inversion with an automatic uniform cerebrospinal fluid zero reference algorithm (MEDI+0). Multiple linear regression analysis was applied to explore the clinical factors influencing cerebral susceptibility in CSVD patients. Correlation analysis and pathway‐specific mediation effects between brain iron levels and motor function were investigated.Results: There were significant differences in the MoCA scores, depression scores, five‐repetition sit‐to‐stand test (5R‐STS) time, and susceptibility values of the caudate nucleus and putamen among the three groups (p < 0.05, FDR correction). Age and history of diabetes played crucial roles in brain iron levels in the caudate nucleus and putamen, which may increase iron levels in the basal ganglia, associated with cognitive decline. Notably, the susceptibility values of the left caudate nucleus and putamen were positively correlated with the 5R‐STS time in CSVD subjects, and there were significant mediating effects of anxiety on the prediction of motor dysfunction with respect to iron levels in the left putamen in CSVD patients.Conclusion: Age, diabetes status, and anxiety may serve as effective intervention targets for individuals with CSVD, especially individuals with cognitive and motor dysfunction. A greater brain iron burden may be a quantitative imaging marker of cognitive and motor dysfunction in CSVD patients.Trial Registration: ISRCTN20008650
- 25 March 2025
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 31 (3) , e70355
Open AccessAssociation of Increased Brain Iron Levels With Anxiety and Motor Dysfunction in Cerebral Small Vessel Disease
Aims: This study explored the relationships between brain iron levels, emotion, and cognitive and motor function in cerebral small vessel disease (CSVD) patients using quantitative susceptibility mapping (QSM).Methods: A total of 208 subjects were enrolled in this study. A brain QSM map was calculated from multiecho GRE data via morphology‐enabled dipole inversion with an automatic uniform cerebrospinal fluid zero reference algorithm (MEDI+0). Multiple linear regression analysis was applied to explore the clinical factors influencing cerebral susceptibility in CSVD patients. Correlation analysis and pathway‐specific mediation effects between brain iron levels and motor function were investigated.Results: There were significant differences in the MoCA scores, depression scores, five‐repetition sit‐to‐stand test (5R‐STS) time, and susceptibility values of the caudate nucleus and putamen among the three groups (p < 0.05, FDR correction). Age and history of diabetes played crucial roles in brain iron levels in the caudate nucleus and putamen, which may increase iron levels in the basal ganglia, associated with cognitive decline. Notably, the susceptibility values of the left caudate nucleus and putamen were positively correlated with the 5R‐STS time in CSVD subjects, and there were significant mediating effects of anxiety on the prediction of motor dysfunction with respect to iron levels in the left putamen in CSVD patients.Conclusion: Age, diabetes status, and anxiety may serve as effective intervention targets for individuals with CSVD, especially individuals with cognitive and motor dysfunction. A greater brain iron burden may be a quantitative imaging marker of cognitive and motor dysfunction in CSVD patients.Trial Registration: ISRCTN20008650
- Open Access
- 24 December 2024
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 7 (1) , fcaf011
Quantitative susceptibility mapping is more sensitive and specific than phase imaging in detecting chronic active multiple sclerosis lesion rims: pathological validation
Quantitative susceptibility mapping and phase imaging are used to identify multiple sclerosis lesions with paramagnetic rims that slowly expand over time and are associated with earlier progression to disability, decreased brain volume and increased frequency of clinical relapse. However, the presence of iron-laden microglia/macrophages at the lesion rim and demyelination within the lesion both contribute to phase and quantitative susceptibility mapping images. Therefore, simultaneous pathological validation is needed to assess accuracies in identifying iron-positive lesions. MRI was performed on 15 multiple sclerosis brain slabs; 32 lesions of interest were processed for myelin, iron and microglial markers. Three experienced readers classified lesions as rim positive or negative on quantitative susceptibility mapping and phase; these classifications were compared with Perls’ stain as the gold standard. All 10 of the quantitative susceptibility mapping-positive lesions had iron-positive rims on histology. Of the 16 phase-positive lesions, only 10 had iron-positive rims on histology. Using Perls’ stain as the ground truth, the positive predictive value was 100% for quantitative susceptibility mapping and 63% for phase; the negative predictive value was 95% for quantitative susceptibility mapping and 94% for phase. Post-mortem imaging results demonstrate that quantitative susceptibility mapping is a more reliable indicator of an iron-positive rim compared with phase imaging.
- 24 December 2024
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 7 (1) , fcaf011
Open AccessQuantitative susceptibility mapping is more sensitive and specific than phase imaging in detecting chronic active multiple sclerosis lesion rims: pathological validation
Quantitative susceptibility mapping and phase imaging are used to identify multiple sclerosis lesions with paramagnetic rims that slowly expand over time and are associated with earlier progression to disability, decreased brain volume and increased frequency of clinical relapse. However, the presence of iron-laden microglia/macrophages at the lesion rim and demyelination within the lesion both contribute to phase and quantitative susceptibility mapping images. Therefore, simultaneous pathological validation is needed to assess accuracies in identifying iron-positive lesions. MRI was performed on 15 multiple sclerosis brain slabs; 32 lesions of interest were processed for myelin, iron and microglial markers. Three experienced readers classified lesions as rim positive or negative on quantitative susceptibility mapping and phase; these classifications were compared with Perls’ stain as the gold standard. All 10 of the quantitative susceptibility mapping-positive lesions had iron-positive rims on histology. Of the 16 phase-positive lesions, only 10 had iron-positive rims on histology. Using Perls’ stain as the ground truth, the positive predictive value was 100% for quantitative susceptibility mapping and 63% for phase; the negative predictive value was 95% for quantitative susceptibility mapping and 94% for phase. Post-mortem imaging results demonstrate that quantitative susceptibility mapping is a more reliable indicator of an iron-positive rim compared with phase imaging.
- 11 October 2024
- Published by Elsevier in Next Research
- Vol. 1 (2)
Recent trends in US federal research support for imaging instrumentation grants to departments of radiology
- 11 October 2024
- Published by Elsevier in Next Research
- Vol. 1 (2)
Recent trends in US federal research support for imaging instrumentation grants to departments of radiology
- Open Access
- 27 September 2023
- Published by Oxford University Press (OUP) in Academic Medicine
- Vol. 99 (1) , 70-75
Pathway to Independence Awards (K99/R00): Funding Dynamics and Prediction of Future National Institutes of Health Research Project Funding
Purpose The authors use the National Institutes of Health (NIH) RePORTER (Research Portfolio Online Reporting Tools) to evaluate funding trends and historic NIH investment increase in the K99 award pathway and examine whether R00 to R01 or R21 achievement time correlates with the future success of an early-stage NIH-funded investigator. Method All K99 awards and funding data in this study were limited to all clinical departments. The authors identified all researchers and awards through a K99 search from fiscal years (FYs) 2007 to 2022 across all clinical departments and investigated trends in K99 awards and funding from NIH FYs 2007 to 2022. They generated an R00 data set and analyzed the K99 to R00 achievement statistics from FYs 2007 to 2022. The authors aggregated NIH annual data files for FYs 2007 to 2021 to generate a master data file of all R01 and R21 awards. They linked R01 and R21 award data to the researcher previously identified through the K99 search and focused on the connection between K99/R00 awardees and subsequent R01 or R21 awards. Results From FY 2008 to FY 2022, the NIH K99 budget increased 127.0%, whereas the NIH program-level budget increased 17.3%. A principal investigator’s mean funding per year significantly decreased as time from R00 to R01 or R21 increased (P < .001); 7 of 15 comparisons differed significantly (2 at P < .01 and 5 at P < .001). Conclusions NIH investment in the K99 award pathway has substantially outpaced the NIH program-level budget increase, and there is a strong association between mean funding per year since the start of the R00 phase and time from R00 to R01 or R21. This analysis may be useful to clinical departments as they evaluate selecting new and retaining current biomedical scientists for independent research positions.
- 27 September 2023
- Published by Oxford University Press (OUP) in Academic Medicine
- Vol. 99 (1) , 70-75
Open AccessPathway to Independence Awards (K99/R00): Funding Dynamics and Prediction of Future National Institutes of Health Research Project Funding
Purpose The authors use the National Institutes of Health (NIH) RePORTER (Research Portfolio Online Reporting Tools) to evaluate funding trends and historic NIH investment increase in the K99 award pathway and examine whether R00 to R01 or R21 achievement time correlates with the future success of an early-stage NIH-funded investigator. Method All K99 awards and funding data in this study were limited to all clinical departments. The authors identified all researchers and awards through a K99 search from fiscal years (FYs) 2007 to 2022 across all clinical departments and investigated trends in K99 awards and funding from NIH FYs 2007 to 2022. They generated an R00 data set and analyzed the K99 to R00 achievement statistics from FYs 2007 to 2022. The authors aggregated NIH annual data files for FYs 2007 to 2021 to generate a master data file of all R01 and R21 awards. They linked R01 and R21 award data to the researcher previously identified through the K99 search and focused on the connection between K99/R00 awardees and subsequent R01 or R21 awards. Results From FY 2008 to FY 2022, the NIH K99 budget increased 127.0%, whereas the NIH program-level budget increased 17.3%. A principal investigator’s mean funding per year significantly decreased as time from R00 to R01 or R21 increased (P < .001); 7 of 15 comparisons differed significantly (2 at P < .01 and 5 at P < .001). Conclusions NIH investment in the K99 award pathway has substantially outpaced the NIH program-level budget increase, and there is a strong association between mean funding per year since the start of the R00 phase and time from R00 to R01 or R21. This analysis may be useful to clinical departments as they evaluate selecting new and retaining current biomedical scientists for independent research positions.
- Open Access
- 5 September 2023
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 6 (9) , e2331905
National Institutes of Health Funding Gaps for Principal Investigators
Early-stage and established investigators compete for a limited supply of funds from the National Institutes of Health (NIH). Despite the allocation of more than $33 billion across 58 368 awards in fiscal year (FY) 2022 alone, obtaining and sustaining NIH funding throughout the career of a principal investigator (PI) remains a formidable challenge.1 Ongoing initiatives aim to address inequalities in funding based on career stage and other demographic characteristics of the scientific workforce, but recent historical data show that 10% of research project grant funding is awarded to the top 1% of PIs.2 A potential consequence of this concentrated funding is that 72.7%, 62.4%, and 63.7% of early-, middle-, and late-stage investigators, respectively, are supported by just 1 research project grant.3 This indicates a heavy reliance on a single award and, consequently, the PI’s ability to successfully obtain a new or renewal award. With a new research project grant funding success rate of 20.7%, many previously funded researchers encounter a funding gap when their NIH funding has concluded, and they receive no ongoing funding from the NIH as an research project grant PI.1
- 5 September 2023
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 6 (9) , e2331905
Open AccessNational Institutes of Health Funding Gaps for Principal Investigators
Early-stage and established investigators compete for a limited supply of funds from the National Institutes of Health (NIH). Despite the allocation of more than $33 billion across 58 368 awards in fiscal year (FY) 2022 alone, obtaining and sustaining NIH funding throughout the career of a principal investigator (PI) remains a formidable challenge.1 Ongoing initiatives aim to address inequalities in funding based on career stage and other demographic characteristics of the scientific workforce, but recent historical data show that 10% of research project grant funding is awarded to the top 1% of PIs.2 A potential consequence of this concentrated funding is that 72.7%, 62.4%, and 63.7% of early-, middle-, and late-stage investigators, respectively, are supported by just 1 research project grant.3 This indicates a heavy reliance on a single award and, consequently, the PI’s ability to successfully obtain a new or renewal award. With a new research project grant funding success rate of 20.7%, many previously funded researchers encounter a funding gap when their NIH funding has concluded, and they receive no ongoing funding from the NIH as an research project grant PI.1
- Open Access
- 1 January 2023
- Published by XMLink in Korean Journal of Radiology
- Vol. 24 (4) , 324-337
Assessing Cerebral Oxygen Metabolism Changes in Patients With Preeclampsia Using Voxel-Based Morphometry of Oxygen Extraction Fraction Maps in Magnetic Resonance Imaging
Zhang Q, et al. Korean J Radiol. 2023 Mar;24:e22. https://doi.org/10.3348/kjr.2022.0652
- 1 January 2023
- Published by XMLink in Korean Journal of Radiology
- Vol. 24 (4) , 324-337
Open AccessAssessing Cerebral Oxygen Metabolism Changes in Patients With Preeclampsia Using Voxel-Based Morphometry of Oxygen Extraction Fraction Maps in Magnetic Resonance Imaging
Zhang Q, et al. Korean J Radiol. 2023 Mar;24:e22. https://doi.org/10.3348/kjr.2022.0652
- Open Access
- 14 June 2022
- Published by MDPI AG in Tomography
- Vol. 8 (3) , 1544-1551
Magnetic Susceptibility Source Separation Solely from Gradient Echo Data: Histological Validation
Quantitative susceptibility mapping (QSM) facilitates mapping of the bulk magnetic susceptibility of tissue from the phase of complex gradient echo (GRE) MRI data. QSM phase processing combined with an model of magnitude of multiecho gradient echo data () allows separation of dia- and para-magnetic components (e.g., myelin and iron) that contribute constructively to value but destructively to the QSM value of a voxel. This technique is validated against quantitative histology—optical density of myelin basic protein and Perls’ iron histological stains of rim and core of 10 ex vivo multiple sclerosis lesions, as well as neighboring normal appearing white matter. We found that source maps are in good qualitative agreement with histology, e.g., showing increased iron concentration at the edge of the rim+ lesions and myelin loss in the lesions’ core. Furthermore, our results indicate statistically significant correlation between paramagnetic and diamagnetic tissue components estimated with and optical densities of Perls’ and MPB stains. These findings provide direct support for the use of magnetic source separation based solely on GRE complex data to characterize MS lesion composition.- 14 June 2022
- Published by MDPI AG in Tomography
- Vol. 8 (3) , 1544-1551
Open AccessMagnetic Susceptibility Source Separation Solely from Gradient Echo Data: Histological Validation
Quantitative susceptibility mapping (QSM) facilitates mapping of the bulk magnetic susceptibility of tissue from the phase of complex gradient echo (GRE) MRI data. QSM phase processing combined with an model of magnitude of multiecho gradient echo data () allows separation of dia- and para-magnetic components (e.g., myelin and iron) that contribute constructively to value but destructively to the QSM value of a voxel. This technique is validated against quantitative histology—optical density of myelin basic protein and Perls’ iron histological stains of rim and core of 10 ex vivo multiple sclerosis lesions, as well as neighboring normal appearing white matter. We found that source maps are in good qualitative agreement with histology, e.g., showing increased iron concentration at the edge of the rim+ lesions and myelin loss in the lesions’ core. Furthermore, our results indicate statistically significant correlation between paramagnetic and diamagnetic tissue components estimated with and optical densities of Perls’ and MPB stains. These findings provide direct support for the use of magnetic source separation based solely on GRE complex data to characterize MS lesion composition. - 6 June 2022
- Published by Wiley in Journal of Neuroimaging
- Vol. 32 (5) , 852-859
Susceptibility source separation from gradient echo data using magnitude decay modeling
Background and Purpose: The objective is to demonstrate feasibility of separating magnetic sources in quantitative susceptibility mapping (QSM) by incorporating magnitude decay rates in gradient echo (GRE) MRI. Methods: Magnetic susceptibility source separation was developed using and compared with a prior method using that required an additional sequence to measure the transverse relaxation rate R 2 . Both susceptibility separation methods were compared in multiple sclerosis (MS) patients ( n = 17). Susceptibility values of negative sources estimated with ‐based source separation in a set of enhancing MS lesions ( n = 44) were correlated against longitudinal myelin water fraction (MWF) changes. Results: In in vivo data, linear regression of the estimated and susceptibility values between the ‐ and the ‐based separation methods performed across 182 segmented lesions revealed correlation coefficient r = .96 and slope close .99. Correlation analysis in enhancing lesions revealed a significant positive association between the increase at 1‐year post‐onset relative to 0 year and the MWF increase at 1 year relative to 0 year ( β = ‐0.144, 95% confidence interval: [–0.199, –0.1], p = .0008) and good agreement between and methods ( r = .79, slope = .95). Conclusions: Separation of magnetic sources based solely on GRE complex data is feasible by combining magnitude decay rate modeling and phase‐based QSM and change may serve as a biomarker for myelin recovery or damage in acute MS lesions.
- 6 June 2022
- Published by Wiley in Journal of Neuroimaging
- Vol. 32 (5) , 852-859
Susceptibility source separation from gradient echo data using magnitude decay modeling
Background and Purpose: The objective is to demonstrate feasibility of separating magnetic sources in quantitative susceptibility mapping (QSM) by incorporating magnitude decay rates in gradient echo (GRE) MRI. Methods: Magnetic susceptibility source separation was developed using and compared with a prior method using that required an additional sequence to measure the transverse relaxation rate R 2 . Both susceptibility separation methods were compared in multiple sclerosis (MS) patients ( n = 17). Susceptibility values of negative sources estimated with ‐based source separation in a set of enhancing MS lesions ( n = 44) were correlated against longitudinal myelin water fraction (MWF) changes. Results: In in vivo data, linear regression of the estimated and susceptibility values between the ‐ and the ‐based separation methods performed across 182 segmented lesions revealed correlation coefficient r = .96 and slope close .99. Correlation analysis in enhancing lesions revealed a significant positive association between the increase at 1‐year post‐onset relative to 0 year and the MWF increase at 1 year relative to 0 year ( β = ‐0.144, 95% confidence interval: [–0.199, –0.1], p = .0008) and good agreement between and methods ( r = .79, slope = .95). Conclusions: Separation of magnetic sources based solely on GRE complex data is feasible by combining magnitude decay rate modeling and phase‐based QSM and change may serve as a biomarker for myelin recovery or damage in acute MS lesions.